TABLE 1.

Patient Characteristics

Patient no.	Sex	Age (y)	Disease	State of disease before RLT	Additional radioimmunotherapy	HSCT	RLT to neutropenia (d)	HSCT to neutrophil reconstitution (d)	Best response	PFS	OS
1	F	50	T-PLL	PD	No	Allogeneic	10	NA*	NA*	NA*	16 d
2	M	53	TCL (NOS)	PD	No	Autologous	11	NA^†	PR	7 mo	56 mo
3	M	50	TCL (hepatosplenic/NOS)	PD	Yes (¹⁸⁸Re)	Allogeneic	11	12	CMR	25 mo	54 mo^‡
4	F	43	T-cell lymphoblastic lymphoma	PD	No	Allogeneic	14	12	CMR	4 mo^‡	4 mo^‡

* Patient 1 died after RLT and HSCT, without reaching neutrophil reconstitution.
↵^†Neutrophil reconstitution was not immediately successful after autologous HSCT but was reached after another conditioning therapy and allogeneic HSCT.
↵^‡Complete metabolic response at last available follow-up.
PFS = progression-free survival; OS = overall survival; T-PLL = T-cell prolymphocytic leukemia; PD = progressive disease; NA = not available; NOS = not otherwise specified; PR = partial response; CMR = complete metabolic response.
Patients 2–4 were alive at last available follow-up.